Thus, after transcription and translation, the GST protein and the protein of interest will be expressed together as a fusion protein
Furthermore, in January 2025, the FDA approved semaglutide (Ozempic ) for reducing the risk of kidney failure and disease progression in patients with diabetes and chronic kidney disease (CKD), making it the first GLP-1 agent indicated for the treatment of CKD (Perkovic et al., 2024)
Future Outlook The Semaglutide Industry size is projected to reach USD 50.04 billion by 2035, growing at a CAGR of 19.74%, driven by increasing diabetes prevalence, rising healthcare expenditure, and innovative drug formulations
Start slowly, make smart food choices, and dont lie down right after eating
Our MedExpress team also recommends rotating your injection sites each time you inject to reduce the possibility of injection site reactions
Frequently Asked Questions Is it safe to take topiramate and Ozempic together